hospitalization from covid by half. dr. levy is a voting members of the fda s advisory committee, infectious disease physician, and director of the physician s vaccine program at boston children s hospital. thank you very much for being here. what will you and/or the fda committee be looking for in terms of these three eau asks? thank you for that, alisyn. it is indeed a very busy month of october at fda. we look forward to a number of meetings. i m aware of no fewer than three meetings coming up this month on the 14th, 15th of october, and then again on the 26th. i believe topics will include potential booster doses for moderna, potential booster dose for johnson & johnson, and then of course considering the pfizer vaccine for 5 to 11-year-old children. i ll point out the merck drug, the potential merck drug sounds